awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33735395-F1EF3B77-5DA0-4EB1-8045-46B9190D5BB0
Q33735395-F1EF3B77-5DA0-4EB1-8045-46B9190D5BB0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33735395-F1EF3B77-5DA0-4EB1-8045-46B9190D5BB0
The cyclooxygenase-2 inhibitors: safety and effectiveness.
P2860
Q33735395-F1EF3B77-5DA0-4EB1-8045-46B9190D5BB0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33735395-F1EF3B77-5DA0-4EB1-8045-46B9190D5BB0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b78d6984535f435b7f0de0bfed519a46e68ed1a9
P2860
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthriti